Lancashire and South Cumbria
Formulary
Formulary
4 Central nervous system
04-12 Other Nervous System medicines
| Acoramidis Beyonttra® |
|
Formulary
|
356 mg film-coated tablets |
 NICE TA1121: Acoramidis for treating transthyretin amyloidosis with cardiomyopathy |
|
| Patisiran Onpattro® |
|
Formulary
|
For treating hereditary transthyretin amyloidosis in line with NICE HST10 guidance via Specialist Centre |
|
|
| Tafamidis |
|
Formulary
|
|
NICE TA984: Tafamidis for treating transthyretin amyloidosis with cardiomyopathy |
|
|
Links
Gabapentinoid (pregabalin and gabapentin):De-prescribing guidance for non-cancer pain in adults in primary care - LSCMMG Paracetamol – prescribing weight-adjusted paracetamol in adults in the community
- LSCMMG: ADHD combined adult and child shared care guideline
- LSCMMG: Opioid reduction: best interests opioid reduction position statement
- LSCMMG: Opioid treatment: patient-prescriber opioid treatment agreement
- LSCMMG: Restless Legs Syndrome in Adults in Primary Care
- NICE TA1121: Acoramidis for treating transthyretin amyloidosis with cardiomyopathy
- NICE TA984: Tafamidis for treating transthyretin amyloidosis with cardiomyopathy